The findings, which appeared today in JAMA Network Open, are strong evidence that buprenorphine, a medication approved by the U.S. Food and Drug Administration to treat opioid use disorder, can be ...

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...

This medicine may be one of the best tools doctors have to fight the fentanyl crisis. Preparation of a dose of Buprenorphine, an opioid that can be administered to people with opioid-use disorder to ...

Please provide your email address to receive an email when new articles are posted on . The study included 227 individuals with OUD given CAM2038 either on weekly or monthly basis. The treatment was ...

Buprenorphine, an evidence-based treatment for opioid use disorder, is currently underprescribed because of concerns that it can cause "precipitated withdrawal," in which the first dose causes sudden, ...

In December 2022, Congress repealed the “X-waiver” requirement, which had limited medical providers’ ability to prescribe buprenorphine-naloxone, one of the three medications approved by the Food and ...

Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...

Buprenorphine is a prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat opioid dependence in adults. Opioid dependence is also called opioid use disorder (OUD), ...